Indonesian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
metrorrhagia/triglyceride
Tautan disimpan ke clipboard
15 hasil
Premenopause contraception with monthly injectable Mesigyna with special emphasis on serum lipid and bone density patterns.
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
This 2-year study compared Mesigyna(R) administered to 49 pre-menopausal women between 38 and 50 years, to 99 women fitted with an IUD (Nova-T). A complete lipoprotein assessment was carried out before treatment and at 6, 12, and 24 months of treatment. A bone densitometry was performed on half of
Clinical comparison of triphasic norgestimate/35 micrograms ethinyl estradiol and monophasic norethindrone acetate/20 micrograms ethinyl estradiol. Cycle control, lipid effects, and user satisfaction.
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
This six-cycle, multicenter, open-label, randomized study compared the clinical experience of two low-dose oral contraceptives (OC): a triphasic OC containing norgestimate (NGM) and 35 micrograms ethinyl estradiol (EE) (Ortho Tri-Cyclen) and a monophasic OC containing norethindrone acetate (NETA)
Twelve years of clinical experience with an oral contraceptive containing 30 micrograms ethinyloestradiol and 150 micrograms desogestrel.
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
The clinical experience with a combined oral contraceptive (COC) containing 150 micrograms desogestrel and 30 micrograms ethinylestradiol is reviewed. Fourteen clinical trials have been reported involving over 44,000 women for more than 190,000 cycles. None of the 17 pregnancies which occurred
A randomized study of metabolic effects of four low-estrogen oral contraceptives: I. Results after 6 cycles.
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
Healthy, non-smoking, normotensive, well-motivated young women were assigned at random to one of four different, commercial, low-estrogen, oral contraceptive products. Measurements of biochemical parameters were made on blood specimens collected from fasting subjects twice during the late
A randomized prospective study of the metabolic effects of four low-estrogen oral contraceptives.
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
Healthy, nonsmoking, normotensive, well-motivated young women were assigned at random to one of four different commercial, low-estrogen oral contraceptives. Measurements of biochemical parameters were made on two blood specimens collected from fasting subjects late in the pretreatment cycle, then
Clinical evaluation of a new combined oral contraceptive desogestrel--ethinylestradiol.
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
A clinical study was performed with a new progestogen, desogestrel, in a 0.15 mg dose associated with 0.03 mg of ethinylestradiol and was administered cyclically during 21 days; 632 cycles were evaluated in 56 women. Side-effects were scarce and generally of a mild nature. Monthly bleeding was
[Estradiol valerate/cyproterone acetate in the treatment of climacteric syndrome].
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
In a prospective study 40 perimenopausal women with climacteric complaints between 45 to 52 years of age were examined. Twenty three (100%) were assigned to treatment with hormonal replacement therapy (Climen fy Schering-estradiol valerate cyproteron acetate) for 6 months. The therapy had to be
[A prospective study of nylestriol on plasma lipids in postmenopausal women].
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
A prospective, double-blind clinical study has been carried out in 90 chinese women with postmenopausal period covering 0.5 to 21 years by administering a synthetic long-acting estriol derivative-nylestriol in the regimen of 2 mg every 2 weeks for 1 year (49 treated and 41 placebo). The result were:
Sequential estrogen-progestin addition to gonadotropin-releasing hormone agonist suppression for the chronic treatment of ovarian hyperandrogenism: a pilot study.
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
The purpose of the study was to evaluate the efficacy and safety of a sequential regimen of estrogen-progestin addition to GnRH agonist suppression in ovarian hyperandrogenism. Eight patients presenting with a polycystic ovary syndrome were treated with an sc implant of GnRH agonist every 4 weeks
Benefits of vaginal estriol cream combined with clonidine HCL for menopausal syndrome treatment.
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
In a group of 25 post menopausal women mean age 57.2 years, treatment with Estriol vagina cream (Ovestin cream from Organon-Holland) gives rise (but within normal limits) to cholesterol, triglycerides and HDL-cholesterol, the protective factor against M. I. A rise in glycohemoglobin (HbA1C)
A transdermal regimen for continuous combined hormone replacement therapy in the menopause.
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
Transdermal systems for oestrogen therapy in the menopause have become very popular. The compliance, however, is impeded by the cyclic addition of oral progestins which leads to monthly withdrawal bleeds. In this pilot study a skin patch releasing 0.05 mg oestradiol and 0.25 mg norethisterone
[Indicators of lipid metabolism and aminotransferase activity in girls with dysfunctional uterine hemorrhage].
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
In a study of 42 girls, aged 12 to 15 years, including 27 patients with dysfunctional uterine bleedings (DUB) and 15 normal controls, the levels of glucose, total lipids, beta-lipoproteins, total cholesterol, as well as beta-lipoprotein, triglycerides, nonesterified fatty acid (NEFA) cholesterol and
Evaluation of a combined oral contraceptive pill in black Zimbabwean women.
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
A prospective exploratory study was carried out on lipid metabolism (41 women); as well as efficacy, acceptability and safety on another 190 women who all were using a combined oral contraceptive pill (OC) containing 30 micrograms Ethinyl oestradiol and 150mg Desogestrel (Marvelon) over a period of
Clinical experience and pharmacological effects of an oral contraceptive containing 20 micrograms oestrogen.
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
The performance of a new low-dose oral contraceptive (Mercilon) containing only 20 micrograms ethinyloestradiol combined with 150 micrograms desogestrel is reviewed. Eight multicentre clinical trials have been completed and provide information on 10,672 women studied over 73,477 cycles. The high
Thyroid Symptomatology across the Spectrum of Hypothyroidism and Impact of Levothyroxine Supplementation in Patients with Severe Primary Hypothyroidism.
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
Database tanaman obat terlengkap yang didukung oleh sains
- Bekerja dalam 55 bahasa
- Pengobatan herbal didukung oleh sains
- Pengenalan herbal melalui gambar
- Peta GPS interaktif - beri tag herba di lokasi (segera hadir)
- Baca publikasi ilmiah yang terkait dengan pencarian Anda
- Cari tanaman obat berdasarkan efeknya
- Atur minat Anda dan ikuti perkembangan berita, uji klinis, dan paten
Ketikkan gejala atau penyakit dan baca tentang jamu yang mungkin membantu, ketik jamu dan lihat penyakit dan gejala yang digunakan untuk melawannya.
* Semua informasi didasarkan pada penelitian ilmiah yang dipublikasikan
